Home » Newsletters » BioWorld Science

BioWorld Science

May 25, 2001

View Archived Issues

2001 milestones highlighted by ImmunoGen

Antiallergic agent codeveloped by Tanabe Seiyaku and Ube licensed for Korean market

Almirall Prodesfarma granted exclusive rights to Japanese antipsychotic

Ariflo highlighted at ATS meeting as promising COPD therapy

In vitro and animal studies support further development of EPI-HNE-4 for CF

AlphaGene identifies novel CEA marker in prostate tissue

IPL-576092, a novel antiinflammatory agent, safe and well tolerated in phase I trials

Large phase III study to evaluate Aromasin following tamoxifen treatment for breast cancer

Joint venture created to manufacture and sell PG2 in China

Transplant 2001: immune function-suppressing effects of FK-778 investigated in primate lymphocytes

Hybrigenics and Institut Curie open laboratory for cancer proteomics research

Imiquimod under investigation for various dermatological conditions

Remune induces allo- and HIV-1-specific responses in phase II study

Company Profile: Big Bear Bio

Preliminary data support new EP4 agonist as potential treatment for acute liver failure

Biosyn obtains license to microbicidal compound for prevention of HIV infection

CAPE efficacy in rat model of colitis attributed to inhibition of NF-kB

Novactyl receives FDA approval to begin clinical trials of herpes labialis drug

Findings from first phase I clinical trial of Panzem presented at ASCO meeting

Revived hope for tesmilifene in breast cancer at YM BioSciences

Company Profile: GeneCure

Nonpeptide inhibitors of methionyl aminopeptidase useful for angiogenesis-related conditions

Sulfonamides designed at Banyu which act as ORL1 antagonists

Melatonin receptor ligands designed at ADIR

Potent PAI-1 inhibitors discovered by ADIR scientists

Tyrosine kinase inhibitors useful for immunological disorders and cancer

Novel antipsoriatic agents from AstraZeneca block the CXCR2 receptor

Novel antifungal agents presented by Japanese lab

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...